Harold Pollack to Buprenorphine
This is a "connection" page, showing publications Harold Pollack has written about Buprenorphine.
Connection Strength
1.734
-
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees. JAMA Netw Open. 2018 09 07; 1(5):e182943.
Score: 0.636
-
Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings. PLoS One. 2022; 17(10):e0276066.
Score: 0.211
-
Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey. Soc Sci Med. 2022 07; 305:115034.
Score: 0.205
-
Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 03; 109(3):434-436.
Score: 0.163
-
State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. Psychiatr Serv. 2018 04 01; 69(4):448-455.
Score: 0.151
-
Non-buprenorphine opioid utilization among patients using buprenorphine. Addiction. 2017 Jun; 112(6):1045-1053.
Score: 0.143
-
Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs. Med Care Res Rev. 2014 Feb; 71(1):43-60.
Score: 0.113
-
HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014 Feb; 49(1):230-48.
Score: 0.111